Delivery Order SPE2DR25D2101-SPE2DR26F47FX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,365.76 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 count), an antimalarial medication commonly used for malaria prophylaxis and treatment in military and federal healthcare settings. The contract was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and utilized firm fixed-price pricing with no set-aside designation. Performance will be executed at the...
- The Defense Logistics Agency awarded a delivery order valued at $5,508.34 to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used by the Department of Defense for malaria prophylaxis in military personnel. This competitively awarded, firm fixed-price delivery order was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,469.83 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Atovaquone-Proguanil 250-100mg in 100-count units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 8, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The antimalarial medication delivery supports federal medical procurement requirements, particularly for military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $7,913.94 for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used for malaria prophylaxis and treatment in military and veteran populations. This firm fixed-price delivery order, awarded July 10, 2025, with completion scheduled for July 11, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $5,418.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication. This non-set-aside delivery order was competitively awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,245.97 to AmerisourceBergen Drug Corp for the supply of Atovaquone-Proguanil 250-100 (100 tablets), a antimalarial medication used primarily for malaria prophylaxis and treatment in military personnel. The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, under firm fixed price terms with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,117.35 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract was awarded on August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The antimalarial medication will support federal medical supply requirements, likely for military personnel...
- The Defense Logistics Agency awarded a delivery order valued at $13,673.47 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100, a pharmaceutical product typically used for malaria prevention and treatment. The contract was awarded on September 16, 2025, with a completion date of September 17, 2025, and employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $15,817.44 to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on December 4, 2025, with completion scheduled for December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Atovaquone-Proguanil is an antimalarial medication commonly used for malaria prophylaxis and...
- The Defense Logistics Agency awarded a $2,637.27 delivery order to AmerisourceBergen Drug Corp for Atovaquone-Proguanil 250-100mg tablets (100 count) on December 16, 2025, with completion targeted for December 17, 2025. This competitively awarded, firm fixed-price order was placed without a set-aside designation and will be fulfilled at the vendor's Conshohocken, Pennsylvania location. Atovaquone-Proguanil is a combination antimalarial medication commonly used for malaria prophylaxis and...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F47FXDelivery Order
The Defense Logistics Agency awarded a $2,492.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 units of Atovaquone-Proguanil 250-100, an antimalarial medication commonly used for malaria prophylaxis in military personnel. Issued on January 12, 2026, with an ultimate completion date of January 13, 2026, this contract represents a routine pharmaceutical procurement executed through DLA's medical supply chain. The award is a non-set-aside contract, indicating open competition, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This IDC serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including brand-name and generic medications, vaccines, and specialized medical commodities. AmerisourceBergen's role as a critical pharmaceutical distributor within the federal medical procurement system enables efficient fulfillment of essential medication requirements for military treatment facilities and veterans' healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 1/11/26 |